CAPELLARI, SABINA
 Distribuzione geografica
Continente #
NA - Nord America 10.022
EU - Europa 7.053
AS - Asia 3.037
AF - Africa 366
SA - Sud America 33
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.527
Nazione #
US - Stati Uniti d'America 9.985
GB - Regno Unito 2.179
IT - Italia 1.465
VN - Vietnam 1.062
DE - Germania 975
CN - Cina 789
SE - Svezia 731
SG - Singapore 616
IN - India 380
UA - Ucraina 363
IE - Irlanda 326
FR - Francia 277
RU - Federazione Russa 222
ZA - Sudafrica 135
EE - Estonia 132
CI - Costa d'Avorio 111
TG - Togo 80
JO - Giordania 79
FI - Finlandia 68
BG - Bulgaria 64
AT - Austria 56
CH - Svizzera 43
BE - Belgio 40
CA - Canada 34
BR - Brasile 27
GR - Grecia 24
SC - Seychelles 24
ES - Italia 20
HK - Hong Kong 18
JP - Giappone 18
NL - Olanda 17
UZ - Uzbekistan 16
IR - Iran 13
AU - Australia 12
NG - Nigeria 10
HR - Croazia 9
LB - Libano 8
PL - Polonia 8
RO - Romania 8
TR - Turchia 7
CZ - Repubblica Ceca 6
KR - Corea 6
PH - Filippine 6
HU - Ungheria 5
IL - Israele 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
DK - Danimarca 3
NO - Norvegia 3
PT - Portogallo 3
SA - Arabia Saudita 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BZ - Belize 2
ID - Indonesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
AL - Albania 1
BD - Bangladesh 1
CO - Colombia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
Totale 20.527
Città #
Southend 1.983
Fairfield 1.187
Houston 1.000
Chandler 935
Ashburn 769
Dong Ket 630
Ann Arbor 594
Woodbridge 588
Seattle 563
Wilmington 526
Singapore 525
Cambridge 450
Princeton 409
Dublin 326
Bologna 319
Jacksonville 224
Westminster 161
Nanjing 154
Redmond 148
Berlin 127
Padova 127
Turin 121
Abidjan 111
Santa Clara 94
Florence 91
Lomé 80
Amman 79
Saint Petersburg 74
Jinan 73
San Diego 73
Shenyang 71
Sofia 64
Milan 62
New York 61
Beijing 56
Hebei 55
Medford 54
Nanchang 51
Changsha 50
Mülheim 44
Des Moines 43
Helsinki 42
Vienna 42
Brussels 39
Olalla 39
Tianjin 35
Boardman 33
Falls Church 30
Los Angeles 30
Verona 29
Dearborn 28
Imola 28
Jiaxing 28
Lappeenranta 26
Redwood City 26
Bern 25
Haikou 25
Mahé 24
Boydton 23
Bremen 23
London 23
Norwalk 23
Toronto 20
Rome 18
Hangzhou 17
Zhengzhou 17
Bühl 16
Garbagnate Milanese 16
Guangzhou 16
Mountain View 16
Taizhou 15
Forlì 14
Taiyuan 14
Tokyo 14
Frankfurt am Main 13
Ningbo 13
Hong Kong 12
Lanzhou 12
San Jose 12
Fuzhou 11
Amsterdam 10
Dallas 10
Kuban 9
Monzuno 9
San Francisco 9
São Paulo 9
Parma 8
Phoenix 8
Shanghai 8
Bengaluru 7
Bergamo 7
Kunming 7
Paris 7
Pune 7
Reggio Emilia 7
Udine 7
Abeokuta 6
Edinburgh 6
Kilburn 6
Palermo 6
Totale 14.192
Nome #
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding 518
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 456
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 235
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 214
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 200
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 196
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 183
A case of fatal familial insomnia in Africa. 179
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 178
Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD) 173
Abnormal in vivo cerebral energy metabolism in Huntington’s disease: preliminary findings 170
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 169
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 161
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 161
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 157
The RET51/FKBP52 complex and its involvement in Parkinson disease. 156
Benign tremulous parkinsonism in a patient with dardarin mutation. 154
Age at onset in genetic prion disease and the design of preventive clinical trials 154
Messenger RNA processing is altered in autosomal dominant leukodystrophy 153
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 152
Alterazione del metabolismo energetico cerebrale in vivo nella malattia di Huntington: dati preliminari 149
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 148
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 147
Color choice preference in cognitively impaired patients: A look inside alzheimer’s disease through the use of lüscher color diagnostic 147
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 145
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 145
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 144
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 144
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 141
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 139
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 136
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 135
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 135
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 131
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 131
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 130
Arylsulphatase A activity in familial parkinsonism: a pathogenetic role? 130
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 130
Lack of association between five serotonin metabolism-related genes and medication overuse headache 129
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 128
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 127
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 127
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. 126
Human figure drawing distinguishes Alzheimer’s patients: a cognitive screening test study 126
Binary transformation of sequencing data to explore functional genetic patterns. 126
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 123
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 123
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 121
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 121
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 120
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 120
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 120
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 119
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 118
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 116
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia 116
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. 115
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 115
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population 114
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients 113
Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-β-hydroxylase deficiency 113
A refined method for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt-Jakob disease is not the rule. 113
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 113
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 112
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 111
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 111
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 111
Nuclear lamins: Functions and clinical implications 110
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 110
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 110
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 109
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 107
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 107
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 107
Creutzfeldt-Jakob disease with E200K PRNP mutation: a case report and revision of the literature 106
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 106
Clinical and genetic study of an Italian family with Parkinsonism. 104
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study 103
Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma 103
null 103
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 103
Observing movement disorders: best practice proposal in the use of video recording in clinical practice 103
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 103
SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE 101
MV2 subtype of sporadic Creutzfeldt-Jakob disease presenting as corticobasal syndrome 101
Eating disorder as a psychiatric onset of juvenile Huntington's disease. 101
Cathepsin D (C224T) Polymorphism in Sporadic and Genetic Creutzfeldt-Jakob Disease 101
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 101
Inherited Creutzfeldt-Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. 101
Allele-specific silencing as treatment for gene duplication disorders: Proof-of-principle in autosomal dominant leukodystrophy 100
Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: A comparative study 99
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience. 99
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 98
Neurosyphilis orofacial dyskinesia: the candy sign. 98
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 98
Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression 98
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 97
The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. 97
Quantifying prion disease penetrance using large population control cohorts 97
Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course. 97
Totale 13.451
Categoria #
all - tutte 54.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.694 0 0 155 484 528 510 639 682 803 342 265 286
2020/20213.465 535 203 83 145 90 188 145 257 290 202 136 1.191
2021/20224.007 386 138 246 212 350 187 87 418 186 382 797 618
2022/20234.230 444 549 192 544 313 298 155 279 708 110 403 235
2023/20241.268 84 182 107 137 109 172 79 110 43 107 75 63
2024/20251.095 239 750 106 0 0 0 0 0 0 0 0 0
Totale 21.083